- Disease
- Friday, 07 Feb 2020
Majority of the U.S. firms in China see revenue hit from coronavirus: AmCham survey
The majority of U.S. firms with operations in China expect a virus outbreak to cut revenue this year, and some are accelerating plans to shift their supply chains out of the country, according to a poll by Shanghai’s American Chamber of Commerce.
Nearly a quarter of the firms forecast revenue would fall by at least 16% this year due to the outbreak, while over a fifth said it would decline by 11-15%. Only 13% of respondents said revenue would see very little or no impact from the virus.
The survey covered 127 companies, including 20 with China-sourced revenues of over $500 million and 27 with China revenues of $100-500 million.
Sixteen percent of respondents expected China’s gross domestic product (GDP) would fall by over 2% due to the outbreak.
The death toll from the virus in China has topped 600 with more than 30,000 people infected. Widespread transportation bans and strict public health measures have disrupted economic activity in much of the country, and factory closures are starting to ripple through global supply chains.
A government economist said last week that China’s economic growth may drop to 5% or even lower due to the outbreak, possibly pushing policymakers into introducing more stimulus measures.
Sources told Reuters that Chinese policymakers are preparing measures, including more fiscal spending and interest rate cuts, amid expectations the outbreak will have a devastating impact on first-quarter growth.
In response to the virus, some survey respondents said they were shifting operations out of China and moving more production to other areas, including India.
Related Industry Updates
Tumor Ablation Market 2021 Strong Revenue, Competitive Outlook by Top Competitors And Forecast To 2027
Apr 27, 2021
Reinsurance: A financial Backstop for Businesses During this Pandemic?
Mar 31, 2020
Japan will sell record amount of extra bonds to combat coronavirus crisis
Apr 07, 2020
2020 Pandemic can Wipe Away Entire Year’s Economic Growth or even more
Mar 12, 2020
Understanding Pulmonary Embolism: Symptoms, Causes, and Treatment
Mar 12, 2026
BioGX and Bosch Healthcare Solutions announce partnership to develop Infectious disease tests for the Vivalytic platform
May 27, 2020
Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease
Jun 08, 2020